Robotic-Assisted Percutaneous Coronary Intervention

Inclusion Criteria: 1. Age\> = 18 years; 2. Symptomatic ischemic heart disease and / or objective evidence of myocardial ischemia with one or more target lesions; 3. Elective for percutaneous procedure (i.e. performed in a non-urgent context) 4. The target lesion (s) must be obstructive, with stenosis diameter \> 50% (visual analysis); 5. The interventional planning of all target lesions should include robotic manipulation in at least one treatment, as judged by the operator; 6. Acceptable candidate for myocardial revascularization surgery. Exclusion Criteria: 1. ST-segment elevation myocardial infarction in the last 48 hours before the index procedure; 2. Ejection fraction \<30%; 3. Impaired renal function (creatinine\> 2.0 mg / dL) or calculated creatinine clearance \<30 ml / min; 4. Platelet count \<100,000 cells / mm 3 or\> 700,000 cells / mm 3; 5. Total Leucocytes count \<3,000 cells / mm 3; 6. Suspected or documented active liver disease (including laboratory evidence of hepatitis); 7. Heart transplant recipient; 8. Allergies known to aspirin, clopidogrel, ticlopidine, ticagrelor, prasugrel, heparin, antiproliferative agents of the limus family, or stainless steel; 9. Patient with a life expectancy of less than 1 month; 10. Any significant medical condition that in the opinion of the investigator may interfere with the patient's ideal participation in this study; 11. Participation in other research in the last 12 months, unless there may be direct benefit to the research subject; 12. Any invasive cardiac or non-cardiac treatment scheduled within the first month after the index procedure. Angiographic exclusion criteria 1. Need for non-robotic (i.e. manual) treatment of another injury in the index procedure or in the first month; 2. Target lesion not accessible by robotic treatment, according to the judgment of the operator; 3. Unprotected coronary artery trunk lesion (stenosis\> 50%); 4. Angiographic thrombus; 5. Target lesion in surgical graft; 6. Total occlusion (TIMI 0 or 1 anterograde flow)